Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03924778 · ClinicalTrials.gov registry record · NA
Modifying Diet to Improve Gut Microbiome
A NA study, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- Not yet
- Registry status
- NA
- Development phase
- 28
- Enrollment target
NCT03924778 is a NA study that has not yet begun recruiting, run by H. Lee Moffitt Cancer Center and Research Institute. The registered enrollment target is 28 participants.
The verdict
NCT03924778, a NA study, has not yet begun recruiting, sponsored by H. Lee Moffitt Cancer Center and Research Institute.
- NOT YET RECRUITING
- Registry status
- NA
- Development phase
- 28 participants
- Enrollment target
Study Summary
The investigators will conduct a 2-arm randomized controlled pilot, feasibility feeding study in which 28 participants will be randomized to receive either a calorie-restricted Dietary Approaches to Stop Hypertension (DASH) diet or a calorie-restricted standard American diet provided by the study for 4 weeks. Participants will be non-Hispanic black or white, generally healthy females (14 black, 14 white). The investigators will collect fecal samples at multiple time points before, during, and after the dietary intervention to analyze for changes in the gut microbiota and functional-level metabolic products. This work will be led by an interdisciplinary team including expertise in bio-behavioral science, microbiology, nutrition science, bioinformatics, and biostatistics all with cross-cutting expertise in health disparities, prevention research, nutrition, the gut microbiota, inflammation and other biomarkers. The rationale for the proposed research is that once the interactions between race, diet, and the gut microbiota are more fully understood, targeted diet modifications may provide new and innovative approaches for the prevention and treatment of obesity and obesity-related diseases.
Interventions
- BEHAVIORAL DASH diet
- BEHAVIORAL standard American diet
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 28 participants |
| Start Date | 2026-07 |
| Est. Completion | 2026-08 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03924778
The ClinicalTrials.gov registry entry for NCT03924778 describes a study currently listed as not yet recruiting, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is H. Lee Moffitt Cancer Center and Research Institute, which has 502 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which DASH diet is the first listed.
NCT03924778 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT03924778 about?
NCT03924778 is a clinical study titled "Modifying Diet to Improve Gut Microbiome". The investigators will conduct a 2-arm randomized controlled pilot, feasibility feeding study in which 28 participants will be randomized to receive either a calorie-restricted Dietary Approaches to Stop Hypertension (DASH) diet or a calorie-restricted standard American diet provided by the study fo...
What is the current status of trial NCT03924778?
This trial is currently not yet recruiting. It is a NA study. The enrollment target is 28 participants. The study started on 2026-07. Estimated completion is 2026-08.
What interventions are being tested in trial NCT03924778?
The interventions under investigation include: DASH diet (BEHAVIORAL), standard American diet (BEHAVIORAL).
Who is sponsoring clinical trial NCT03924778?
This trial is sponsored by H. Lee Moffitt Cancer Center and Research Institute, which has 502 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.